Skip to content

Minimum effective dose of lactulose for intestinal function. exploratory study

Minimum effective dose of lactulose for intestinal function. exploratory study - Minimum effective dose of lactulose for intestinal function.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021219
Enrollment
30
Registered
2016-03-15
Start date
2016-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intake of lactulose 1, 2, 3g/day for 2weeks sequentially

Sponsors

Showa Women's University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects with feces frequency 2-4 times / week

Exclusion criteria

Exclusion criteria: 1) Subjects with severe hepatic, renal, heart, gastrointestinal, cerebrovascular, endocrine, metabolic or infection diseases. 2) Subjects with the history of gastrointestinal resection. 3) Subjects with gastrointestinal dysfunction such as irritable bowel syndrome or inflammatory bowel disease. 4) Subjects who use medicines or supplements that may influence feces frequency; e.g. antibiotics, probiotics, laxatives, antidiarrheals, fibers. 5) Subjects with milk allergy. 6) Subjects who participate another study. 7) Subjects who are judged inappropriate for the study by the investigator or the physician.

Design outcomes

Primary

MeasureTime frame
Feces frequency, Feces hardness

Secondary

MeasureTime frame
Intestinal bacteria number

Countries

Japan

Contacts

Public ContactHisakazu Iino

Showa Women's University Graduate School, Science for Living System

iino@swu.ac.jp03-3411-4828

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026